> ## Content Index
> Fetch the complete content index at: https://www.coios.me/llms.txt
> Use this file to discover other available public pages before exploring further.

# Head and neck cancer in New Zealand: rising oropharyngeal rates and unequal early deaths
- URL: https://www.coios.me/head-and-neck-cancer-in-new-zealand-rising-oropharyngeal/
- Published: 2026-10-25T11:49:24.000Z
- Updated: 2026-10-26T07:06:27.000Z
- Description: New Zealand oropharyngeal cancer rates rose in 2009-2020, with higher two-year deaths for Māori, Pacific Peoples and the most deprived.
- Author: Daniel Ryan
- Tags: Health today, Cancer, New Zealand, #peer-reviewed, #confirms, #item, #source-2026-10, #score-60

This national cohort used the New Zealand Cancer Registry to identify 6,980 primary head and neck cancers in 2009-2020\. Overall incidence was 13.5 per 100,000 person-years, and oropharyngeal cancer rose from 3.4 in 2009-2011 to 4.9 in 2018-2020\. Incidence was higher in males, older adults, Māori, Pacific Peoples and the most deprived areas. Within two years 25.2% had died: 44.4% for hypopharyngeal, 30.9% for oral cavity and 22.7% for oropharyngeal cancer. After adjustment, two-year mortality was higher for Māori, Pacific Peoples and the most deprived quintile. Adjustment covered only available sociodemographic factors and treatment timing, and the outcome was all-cause death.

*Why it is interesting: Oropharyngeal cancer now drives the rise in head and neck cancer in New Zealand. Higher two-year mortality for Māori, Pacific Peoples and the most deprived persisted after adjustment.*

Source

[Cancer Epidemiology, 23 October 2026](https://doi.org/10.1016/j.canep.2026.103264?ref=coios.me)

Paper

Head and neck cancer incidence and two-year mortality in Aotearoa New Zealand, 2009-2020: a national population-based cohort study

Authors

Chauhan AS, Davie G, Barson D, Parackal SM, Russell-Camp T, Wong A

DOI

10.1016/j.canep.2026.103264

Type

Peer-reviewed article

Design

National population-based retrospective cohort, New Zealand Cancer Registry, n=6,980 head and neck cancer diagnoses, 2009-2020

Verdict

Confirms prior evidence

Driver

[Cancer](https://www.coios.me/d-cancer/)

Free full text

[Free to read at the publisher](https://doi.org/10.1016/j.canep.2026.103264?ref=coios.me)

Abstract — the authors' own words, CC BY

Background

Head and neck cancer (HNC) imposes a substantial burden in Aotearoa New Zealand (AoNZ), yet contemporary population-level data on incidence and early mortality across sociodemographic groups remain limited. Methods

This population-based retrospective cohort study used New Zealand Cancer Registry to identify all primary HNC diagnoses from 2009 to 2020 (n = 6980). The cases were classified according to ICD-10 subsites. Incidence rates (IRs), age-standardised IRs, and age-standardised rate ratios were estimated by age, sex, ethnicity, socioeconomic deprivation, and rurality. Regression models were used to estimate annual percentage change in IRs and to estimate adjusted risk ratios for two-year all-cause mortality. Results

In total 6980 people were diagnosed with HNC; an overall incidence rate of 13.5 per 100,000 person-years (PY). Oropharyngeal cancer (OPC), the most common subsite, increased from 3.4 per 100,000 PY in 2009-2011-4.9 per 100,000 PY in 2018-2020, whereas IRs for oral cavity cancer (OCC), the second most common, were more stable. HNC IRs were higher among males, older adults, Māori, Pacific Peoples and people living in the most socioeconomically deprived areas, with subsite-specific differences: Māori experienced higher OPC incidence rates, while Pacific Peoples experienced higher OCC IRs. Within two years of diagnosis, 25.2% of patients had died. Two-year all-cause mortality was 44.4% for hypopharyngeal cancer, 30.9% for OCC, and 22.7% for OPC. Among people diagnosed with HNC, after adjusting for available sociodemographic factors and treatment timing, two-year all-cause mortality was higher for Māori, Pacific Peoples, and those in the most deprived quintile. Rurality showed no consistent association with incidence or two-year mortality. Conclusions

These findings indicate an OPC-driven shift in HNC epidemiology in AoNZ and a persistent inequitable burden of both disease occurrence and early mortality, supporting stronger surveillance and equity-focused cancer-control responses.